398 related articles for article (PubMed ID: 27784794)
61. Activity of protease-activated receptors in the human submucous plexus.
Mueller K; Michel K; Krueger D; Demir IE; Ceyhan GO; Zeller F; Kreis ME; Schemann M
Gastroenterology; 2011 Dec; 141(6):2088-2097.e1. PubMed ID: 21875497
[TBL] [Abstract][Full Text] [Related]
62. C1-inhibitor influence on platelet activation by thrombin receptors agonists.
Tarandovskiy ID; Buehler PW; Karnaukhova E
Clin Appl Thromb Hemost; 2022; 28():10760296221120422. PubMed ID: 35996317
[TBL] [Abstract][Full Text] [Related]
63. Annexin V binding to platelets is agonist, time and temperature dependent.
Ramstrom S; O'Neill S; Dunne E; Kenny D
Platelets; 2010; 21(4):289-96. PubMed ID: 20230207
[TBL] [Abstract][Full Text] [Related]
64. Adenylate cyclase inhibition is required for normal redistribution of platelet surface GPIb in response to PAR1 activation.
Pouget T; Pillois X; Fiore M
Thromb Res; 2019 Jan; 173():151-154. PubMed ID: 30530120
[No Abstract] [Full Text] [Related]
65. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
Lee H; Sturgeon SA; Jackson SP; Hamilton JR
Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
[TBL] [Abstract][Full Text] [Related]
66. Role of Galphaq and phospholipase C-beta2 in human platelets activation by thrombin receptors PAR1 and PAR4: studies in human platelets deficient in Galphaq and phospholipase C-beta2.
Vaidyula VR; Rao AK
Br J Haematol; 2003 May; 121(3):491-6. PubMed ID: 12716374
[TBL] [Abstract][Full Text] [Related]
67. Differential anti-thrombotic benefit and bleeding risk profiles of antagonists of protease-activated receptor 1 and 4 in Cynomolgus Macaques.
Wickham LA; Sitko G; Stranieri-Michener M; Handt L; Basso A; Fried S; Chu L; Maderia M; Owens K; Castriota G; Chen Z; Metzger JM; Imbriglio J; Wang X; Cai TQ
Thromb Res; 2016 Sep; 145():133-9. PubMed ID: 27318768
[TBL] [Abstract][Full Text] [Related]
68. Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones.
Vellani V; Kinsey AM; Prandini M; Hechtfischer SC; Reeh P; Magherini PC; Giacomoni C; McNaughton PA
Mol Pain; 2010 Sep; 6():61. PubMed ID: 20875131
[TBL] [Abstract][Full Text] [Related]
69. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries.
Hamilton JR; Moffatt JD; Frauman AG; Cocks TM
J Cardiovasc Pharmacol; 2001 Jul; 38(1):108-19. PubMed ID: 11444493
[TBL] [Abstract][Full Text] [Related]
70. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
Jiang L; Luan Y; Miao X; Sun C; Li K; Huang Z; Xu D; Zhang M; Kong F; Li N
Br J Cancer; 2017 Aug; 117(5):695-703. PubMed ID: 28697175
[TBL] [Abstract][Full Text] [Related]
71. Cathepsin G activates protease-activated receptor-4 in human platelets.
Sambrano GR; Huang W; Faruqi T; Mahrus S; Craik C; Coughlin SR
J Biol Chem; 2000 Mar; 275(10):6819-23. PubMed ID: 10702240
[TBL] [Abstract][Full Text] [Related]
72. [Mechanism of action of protease-activated receptors 1 and 4 in platelet activation].
Han Y; Pasquet JM; Nurden A; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):495-8. PubMed ID: 14575544
[TBL] [Abstract][Full Text] [Related]
73. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1.
Poullis M; Manning R; Laffan M; Haskard DO; Taylor KM; Landis RC
J Thorac Cardiovasc Surg; 2000 Aug; 120(2):370-8. PubMed ID: 10917956
[TBL] [Abstract][Full Text] [Related]
74. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity.
Andersen H; Greenberg DL; Fujikawa K; Xu W; Chung DW; Davie EW
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11189-93. PubMed ID: 10500152
[TBL] [Abstract][Full Text] [Related]
75. Role of protease-activated and ADP receptor subtypes in thrombin generation on human platelets.
Dorsam RT; Tuluc M; Kunapuli SP
J Thromb Haemost; 2004 May; 2(5):804-12. PubMed ID: 15099288
[TBL] [Abstract][Full Text] [Related]
76. Oligosaccharide Blocks PAR1 (Proteinase-Activated Receptor 1)-PAR4-Mediated Platelet Activation by Binding to Thrombin Exosite II and Impairs Thrombosis.
Li S; Wang W; Lin L; Yang L; Cai Y; Yang X; Zhang T; Xiao C; Yan H; Gao N; Zhao J
Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):253-266. PubMed ID: 36519467
[TBL] [Abstract][Full Text] [Related]
77. [Effect of protein kinase C and calcium on the thrombin receptors activation].
Han Y; Wang ZY; Xie Y; Zhang W; Dai L; Shen WH; Wu DP; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):154-7. PubMed ID: 18788611
[TBL] [Abstract][Full Text] [Related]
78. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
79. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3.
Wu CC; Hwang TL; Liao CH; Kuo SC; Lee FY; Lee CY; Teng CM
Thromb Haemost; 2002 Jun; 87(6):1026-33. PubMed ID: 12083482
[TBL] [Abstract][Full Text] [Related]
80. Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human platelets.
Han X; de la Fuente M; Nieman MT
Res Pract Thromb Haemost; 2021 Jan; 5(1):104-110. PubMed ID: 33537534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
